The global neuroscience antibodies and assays market size is expected to reach USD 7.06 Billion by 2028 at a CAGR of 10.4%, according to the latest report by Reports and Data. Increasing prevalence of neurological disorders, rapid advancements in neurological research, and growing support by government and healthcare organizations to accelerate drug discovery and development for neurological disorders are key factors expected to drive market revenue growth over the forecast period. Increasing research and development in biopharmaceutical sector and rising demand for high-quality neuroscience antibodies to study novel and potential drug targets are also expected to drive market growth going ahead.
Neuroscience is a multidisciplinary field of science focused on studying the structure and function of nervous system. It comprises an integrated analysis of multiple cell types, tissues, and organs using different techniques. Recent advancements in neuroscience research has resulted in increased reliance on antibodies and immunodetection to understand the pathways and targets of neurological diseases. Antibodies, peptides, and proteins have expanded the scope of different areas of neuroscience research. Antibody based approaches are critical tools in cellular and molecular neuroscience and has increased the knowledge about the abundance, distribution, function, and structure of proteins in the brain. Antibody-based methods are widely used in localization, isolation, and characterization of target proteins that form a fundamental base of neuroscience research. Antibodies targeting specific neurological disorders such as Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, and other neurological diseases are widely available, and this is expected to further boost neuroscience research activities and contribute to market growth going ahead.
Top Companies Profiled in the Report Include:
Thermo Fisher Scientific, Inc., Abcam, Bio-Rad, Merck KGaA, BioLegend, Cell Signaling Technology, F. Hoffmann-La Roche, GenScript, Rockland Immunochemicals, Santa Cruz Biotechnology, Siemens, and Tecan.
To receive a sample copy of the global Neuroscience Antibodies and Assays Market report, visit @ https://www.reportsanddata.com/download-summary-form/4060
Neuroscience Antibodies and Assays Market Overview:
The pharma and healthcare industry has undergone a revolutionary change owing to the COVID-19 pandemic with individuals increasing their focus on health and wellness. Companies operating in the industry have invested heavily in clinical trials and research studies to develop medications to cater to the growing unmet clinical demand on a global level. Implementation of cutting-edge technology in healthcare sector and increasing investment in research and development have contributed significantly to revenue growth of the market in the recent past. In addition, availability of favorable health insurance and reimbursement policies have also positively impacted the healthcare sector with more and more individuals opting to get treatment at hospital and clinical facilities. Rapid development of novel drugs and pharmaceuticals, increasing incidence of lifestyle and chronic diseases, establishment of state-of-the-art healthcare facilities, and rising availability of over-the-counter medications have significantly contributed to the revenue growth of the market.
Major Highlights of the Neuroscience Antibodies and Assays Market Report:
- The Neuroscience Antibodies and Assays Market analysis report offers an in-depth study of the potential market growth opportunities and challenges.
- The report dives deeper into the market and explains the dynamic factors bolstering market growth.
- The report deeply assesses the current, historical market size, market share, and revenue growth rates to offer accurate market projections for the forecast period.
- The report analyzes the Neuroscience Antibodies and Assays Market presence across major regions of the world.
- It determines the production consumption capacities and demand supply dynamics of each regional market.
- The report further illustrates the intense competition among the key market players and highlights their effective business expansion plans and strategies.
- It provides company overview and SWOT analysis of each of the market players.
Additionally, the report consists a detailed analysis of the segmentation of the Neuroscience Antibodies and Assays Market based on product types and end-use/application offered in the Neuroscience Antibodies and Assays Market.
Product Outlook (Revenue, USD Billion; 2018-2028)
- Primary Antibodies
- Secondary Antibodies
- Assay Kits
- Microplate Readers
- Immunoassay Analyzers
- Other Instruments
Technology Outlook (Revenue, USD Billion; 2018-2028)
- Western Blotting
- Others Immunoassays Technologies
- Molecular Diagnostics
- Clinical Chemistry
- Other Technologies
Application Outlook (Revenue, USD Billion; 2018-2028)
- In Vitro Diagnostics
- Drug Discovery and Development
End-use Industry Outlook (Revenue, USD Billion; 2018-2028)
- Pharmaceutical and Biopharmaceutical Companies
- Academic and Research Institutes
- Hospital and Diagnostic Centers
Key Regional Markets Studied in the Report:
- North America (U.S., Canada)
- Europe (U.K., Italy, Germany, France, Rest of EU)
- Latin America (Chile, Brazil, Argentina, Rest of Latin America)
- Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
- The Middle East Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
Read More Reports –
Foot and Ankle Devices Market – https://www.reportsanddata.com/report-detail/foot-and-ankle-devices-market
Neuroscience Antibodies and Assays Market – https://www.reportsanddata.com/report-detail/stethoscope-market
Dermatology Devices Market – https://www.reportsanddata.com/report-detail/dermatology-devices-market
Tissue Ablation Products Market – https://www.reportsanddata.com/report-detail/tissue-ablation-products-market
Sperm Separation Method Market – https://www.reportsanddata.com/report-detail/sperm-separation-method-market
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.
To know more about the Neuroscience Antibodies and Assays Market report @ https://www.reportsanddata.com/press-release/global-neuroscience-antibodies-and-assays-market
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: [email protected]